Pharmacy Medical News about HAART

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Effective Treatment of Patients in a Deep Salvage Situation with Non-Active HAART: Experiences with the Expert Advice System RADATA
Infection, 11/04/09

Lorenzen T et al. – Despite extensive pre–treatment and multiple resistances against prescribed HAART, the patients demonstrated a decline in viral load and a stable CD4–cell count over the observation period. The activity of antiretroviral regimens is not exclusively explained by the current algorithms used for estimating antiretroviral drug activity.

<< Previous
MDR1 polymorphism role in patients treated with cetuximab and...

Next >>
ViiV Healthcare launches: A new specialist HIV company dedicated...

Epidemiology and therapy of pain and depression during HIV and AIDS
Schmerz, 10/01/09 Relevance Score: 90%

Impact of Highly Active Antiretroviral Therapy (HAART) on AIDS and Death in a Cohort of Vertically HIV Type 1-Infected Children
AIDS Research and Human Retroviruses, 11/12/09 Relevance Score: 84%

Treatment partners and adherence to HAART in Central Mozambique
AIDS Care, 11/06/09 Relevance Score: 84%

Primary HIV infection
Practice Nursing, 10/13/09 Relevance Score: 84%

Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA
Journal of Clinical Virology, 10/06/09 Relevance Score: 84%